首页 > 最新文献

International Journal of Infection最新文献

英文 中文
Performance of Students and Nursing Staff in Nosocomial Infection Control in Behbahan City 贝巴汉市学生及护理人员在医院感染控制中的表现
Pub Date : 2020-11-11 DOI: 10.5812/iji.107100
H. Mashali, Mohamad Kheibar, L. Dehghani, Nasrin Kheibar
Background: Considering the fundamental role of nursing staff and students in patient care and nosocomial infection control. Objectives: This study aimed to evaluate and compare the performance of students and nursing staff in nosocomial infection control in Behbahan city in 2019. Methods: This is a descriptive-analytical study. The participants were 217 nursing staff and students of three hospitals in Behbahan who were selected by random sampling. The data gathering tool was a questionnaire that consisted of demographic information and five common nursing procedures. The performance measurement criterion was based on fulfilling or not fulfilling standards. After gathering the data, they were analyzed by statistical tests, including ANOVA and Pearson correlation in SPSS 16 software. Results: The participants were 157 nursing staff and 60 nursing students. In line with the main objective of the study, the results showed that the average performance scores of students (152.9 ± 12.5) and nursing staff (15.5 ± 13.2) were at a good level, and there was no statistically significant difference between the performance of students and nursing staff (P = 0.08). Also, there was no statistically significant difference between the nursing staff of three hospitals (P = 0.76). However, there was a statistically significant difference between the performance scores of staff in different wards (P < 0.001). The CCU and NICU personnel outperformed other wards’ personnel. Conclusions: Based on these findings, it can be concluded that nurses at different levels of education, with different demographic characteristics, and different work environments have a good performance in controlling infections. This is a strong point in the nursing profession.
背景:考虑护理人员和学生在病人护理和医院感染控制中的基础性作用。目的:本研究旨在评价和比较2019年贝巴汉市学生和护理人员在医院感染控制方面的表现。方法:采用描述性分析研究。研究对象为贝巴汉市三所医院的217名护理人员和学生。数据收集工具是一份问卷,包括人口统计信息和五种常见护理程序。绩效衡量标准以满足或不满足标准为基础。收集数据后,在SPSS 16软件中进行统计学检验,包括方差分析和Pearson相关分析。结果:调查对象为157名护理人员和60名护生。与研究的主要目的一致,结果显示学生的平均绩效得分(152.9±12.5)分与护理人员的平均绩效得分(15.5±13.2)分均处于较好的水平,学生与护理人员的绩效得分差异无统计学意义(P = 0.08)。三家医院护理人员之间的差异无统计学意义(P = 0.76)。但不同病区员工绩效得分差异有统计学意义(P < 0.001)。CCU和NICU人员表现优于其他病房人员。结论:不同文化程度、不同人口统计学特征、不同工作环境的护士在控制感染方面表现较好。这是护理专业的强项。
{"title":"Performance of Students and Nursing Staff in Nosocomial Infection Control in Behbahan City","authors":"H. Mashali, Mohamad Kheibar, L. Dehghani, Nasrin Kheibar","doi":"10.5812/iji.107100","DOIUrl":"https://doi.org/10.5812/iji.107100","url":null,"abstract":"Background: Considering the fundamental role of nursing staff and students in patient care and nosocomial infection control. Objectives: This study aimed to evaluate and compare the performance of students and nursing staff in nosocomial infection control in Behbahan city in 2019. Methods: This is a descriptive-analytical study. The participants were 217 nursing staff and students of three hospitals in Behbahan who were selected by random sampling. The data gathering tool was a questionnaire that consisted of demographic information and five common nursing procedures. The performance measurement criterion was based on fulfilling or not fulfilling standards. After gathering the data, they were analyzed by statistical tests, including ANOVA and Pearson correlation in SPSS 16 software. Results: The participants were 157 nursing staff and 60 nursing students. In line with the main objective of the study, the results showed that the average performance scores of students (152.9 ± 12.5) and nursing staff (15.5 ± 13.2) were at a good level, and there was no statistically significant difference between the performance of students and nursing staff (P = 0.08). Also, there was no statistically significant difference between the nursing staff of three hospitals (P = 0.76). However, there was a statistically significant difference between the performance scores of staff in different wards (P < 0.001). The CCU and NICU personnel outperformed other wards’ personnel. Conclusions: Based on these findings, it can be concluded that nurses at different levels of education, with different demographic characteristics, and different work environments have a good performance in controlling infections. This is a strong point in the nursing profession.","PeriodicalId":13989,"journal":{"name":"International Journal of Infection","volume":"34 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84591510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frequency and Antimicrobial Susceptibility of Bacterial Agents Causing Peritoneal Dialysis-Related Peritonitis: A Two-Center Experience 引起腹膜透析相关性腹膜炎的细菌药物的频率和抗菌药物敏感性:双中心经验
Pub Date : 2020-10-31 DOI: 10.5812/iji.104037
Fariba Shirvani, N. Hooman, A. Karimi, S. Armin, A. Fahimzad, Roxana Mansour Ghanaei, Sedigheh RafieeTabatabaei, F. Fallah
Background: Peritonitis remains a significant complication of peritoneal dialysis (PD) in children. Objectives: The current study aimed to evaluate the causative agents of PD-related peritonitis in pediatric patients treated by continuous ambulatory peritoneal dialysis (CAPD) in order to provide evidence for improving the empirical treatment of PD-related peritonitis and avoid antimicrobial resistance. Methods: The medical records of children diagnosed with PD-related peritonitis hospitalized at Mofid and Ali-Asghar Children’s Hospitals from January 2018 to December 2019 were retrospectively reviewed. Cases of relapsing peritonitis and fungal peritonitis were excluded. Data on demographics, clinical manifestations, para-clinical evaluations, peritoneal fluid culture and antibiogram, and antibiotic regimen were analyzed. Results: A total of 23 CAPD children aged 1 - 17 years were hospitalized with a confirmed diagnosis of PD-related peritonitis, accounting for a total of 27 peritonitis cases. The most frequent manifestation of peritonitis was cloudy dialysate (85.2%), followed by abdominal pain (59.3%). Gram-negative organisms were isolated in 48.1% of cases, and 4 cases had negative cultures. The frequency of antibiotic prescription within 14 days of admission was significantly higher in culture-negative cases (P = 0.002), and abdominal pain was more prevalent in Gram-negative peritonitis (P = 0.004). All Gram-negative organisms were sensitive to ceftazidime and imipenem; while 61.6% of them were sensitive to gentamycin. All Gram-positive organisms were sensitive to cefazolin, and vancomycin was effective against all Staphylococcus strains. Oxacillin resistance was reported in 50% of Staphylococcus strains. Conclusions: PD-related peritonitis should be suspected even in cases with clear dialysis effluent who present with other manifestations of peritonitis such as fever or abdominal pain. Moreover, intraperitoneal administration of a first-generation cephalosporin (cefazolin) combined with ceftazidime was an appropriate therapeutic option for empiric therapy.
背景:腹膜炎仍然是儿童腹膜透析(PD)的一个重要并发症。目的:本研究旨在评价儿科持续门诊腹膜透析(CAPD)患者pd相关性腹膜炎的致病因素,为改进pd相关性腹膜炎的经验性治疗及避免耐药提供依据。方法:回顾性分析2018年1月至2019年12月Mofid和Ali-Asghar儿童医院住院诊断为pd相关性腹膜炎的儿童病历。排除复发性腹膜炎和真菌性腹膜炎。分析人口统计学、临床表现、临床评价、腹膜液培养和抗生素图以及抗生素治疗方案的数据。结果:共有23例1 ~ 17岁CAPD患儿确诊为pd相关性腹膜炎住院,占27例腹膜炎。腹膜炎最常见的表现是透析液混浊(85.2%),其次是腹痛(59.3%)。检出革兰氏阴性菌48.1%,阴性培养4例。入院14 d内抗生素处方频次培养阴性患者明显高于住院患者(P = 0.002),革兰氏阴性腹膜炎患者腹痛发生率较高(P = 0.004)。革兰氏阴性菌对头孢他啶和亚胺培南均敏感;61.6%的人对庆大霉素敏感。所有革兰氏阳性菌对头孢唑林均敏感,万古霉素对所有葡萄球菌均有效。据报道,50%的葡萄球菌耐氧西林。结论:即使透析流出物清澈,伴有其他腹膜炎表现,如发热或腹痛,也应怀疑pd相关性腹膜炎。此外,腹腔内给药第一代头孢菌素(头孢唑林)联合头孢他啶是经验治疗的适当治疗选择。
{"title":"Frequency and Antimicrobial Susceptibility of Bacterial Agents Causing Peritoneal Dialysis-Related Peritonitis: A Two-Center Experience","authors":"Fariba Shirvani, N. Hooman, A. Karimi, S. Armin, A. Fahimzad, Roxana Mansour Ghanaei, Sedigheh RafieeTabatabaei, F. Fallah","doi":"10.5812/iji.104037","DOIUrl":"https://doi.org/10.5812/iji.104037","url":null,"abstract":"Background: Peritonitis remains a significant complication of peritoneal dialysis (PD) in children. Objectives: The current study aimed to evaluate the causative agents of PD-related peritonitis in pediatric patients treated by continuous ambulatory peritoneal dialysis (CAPD) in order to provide evidence for improving the empirical treatment of PD-related peritonitis and avoid antimicrobial resistance. Methods: The medical records of children diagnosed with PD-related peritonitis hospitalized at Mofid and Ali-Asghar Children’s Hospitals from January 2018 to December 2019 were retrospectively reviewed. Cases of relapsing peritonitis and fungal peritonitis were excluded. Data on demographics, clinical manifestations, para-clinical evaluations, peritoneal fluid culture and antibiogram, and antibiotic regimen were analyzed. Results: A total of 23 CAPD children aged 1 - 17 years were hospitalized with a confirmed diagnosis of PD-related peritonitis, accounting for a total of 27 peritonitis cases. The most frequent manifestation of peritonitis was cloudy dialysate (85.2%), followed by abdominal pain (59.3%). Gram-negative organisms were isolated in 48.1% of cases, and 4 cases had negative cultures. The frequency of antibiotic prescription within 14 days of admission was significantly higher in culture-negative cases (P = 0.002), and abdominal pain was more prevalent in Gram-negative peritonitis (P = 0.004). All Gram-negative organisms were sensitive to ceftazidime and imipenem; while 61.6% of them were sensitive to gentamycin. All Gram-positive organisms were sensitive to cefazolin, and vancomycin was effective against all Staphylococcus strains. Oxacillin resistance was reported in 50% of Staphylococcus strains. Conclusions: PD-related peritonitis should be suspected even in cases with clear dialysis effluent who present with other manifestations of peritonitis such as fever or abdominal pain. Moreover, intraperitoneal administration of a first-generation cephalosporin (cefazolin) combined with ceftazidime was an appropriate therapeutic option for empiric therapy.","PeriodicalId":13989,"journal":{"name":"International Journal of Infection","volume":"334 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75934157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fever Management of Critically Ill Patients with COVID-19 Infection: Less is More? COVID-19 感染重症患者的发热管理:少即是多?
Pub Date : 2020-10-31 DOI: 10.5812/iji.107422
A. Mahmoodpoor, S. Sanaie, Mohammad-Salar Hosseini
{"title":"Fever Management of Critically Ill Patients with COVID-19 Infection: Less is More?","authors":"A. Mahmoodpoor, S. Sanaie, Mohammad-Salar Hosseini","doi":"10.5812/iji.107422","DOIUrl":"https://doi.org/10.5812/iji.107422","url":null,"abstract":"<jats:p />","PeriodicalId":13989,"journal":{"name":"International Journal of Infection","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78126231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Detection of OqxAB and QepA Efflux Pumps and Their Association with Antibiotic Resistance in Klebsiella pneumoniae Isolated From Urinary Tract Infection 尿路感染肺炎克雷伯菌OqxAB和QepA外排泵检测及其与抗生素耐药性的关系
Pub Date : 2020-10-26 DOI: 10.5812/iji.107397
Manijeh Dehnamaki, M. Ghane, L. Babaeekhou
Background: The emergence and spread of drug resistance among Klebsiella pneumoniae clinical isolates have limited the treatment options for these bacteria. Efflux pumps are considered as one of the key mechanisms of antibiotic resistance in K. pneumoniae isolates. Objectives: The present study aimed to detect oqxA, oqxB, and qepA efflux genes in K. pneumoniae isolated from urinary tract infection (UTI) and survey their association with antibiotic resistance. Methods: In total, 100 K. pneumoniae isolates were obtained from urine samples, and an antimicrobial susceptibility test was conducted using the disk diffusion method according to the Clinical and Laboratory Standards Institute (CLSI) instructions. Polymerase chain reaction (PCR) was done for the detection of efflux pump genes including, oqxA, oqxB, and qepA, and their association was statistically analyzed with resistance to antibiotics. Results: The highest rate of resistance was obtained against trimethoprim-sulfamethoxazole (72%), amikacin (70%), levofloxacin (68%), gentamicin (56%), ceftazidime (56%), and ceftriaxone (51%), and the lowest resistance was against imipenem (10%). Thirty one percent of isolates were multidrug resistant (MDR). Molecular distribution test showed that 57% and 56% of isolates carried the oqxA and oqxB genes, respectively. Also, the frequency of qepA genes was 21%. The presence of oqxA/oqxB and qepA efflux genes were significantly associated with fluoroquinolone and beta-lactam resistance phenotypes (P < 0.05). Conclusions: The high frequency of efflux genes showed that this resistance mechanism is the main way, along with other resistance mechanisms in K. pneumoniae isolates. It is necessary to adopt appropriate treatment to reduce the incidence of resistance.
背景:肺炎克雷伯菌临床分离株耐药的出现和传播限制了这些细菌的治疗选择。外排泵被认为是肺炎克雷伯菌分离株抗生素耐药的关键机制之一。目的:检测尿路感染(UTI)肺炎克雷伯菌oqxA、oqxB和qepA外排基因,探讨其与抗生素耐药性的关系。方法:从尿标本中分离肺炎克雷伯菌100株,按照临床与实验室标准协会(CLSI)的指导,采用纸片扩散法进行药敏试验。采用聚合酶链反应(Polymerase chain reaction, PCR)检测外排泵基因oqxA、oqxB、qepA,并统计分析其与抗生素耐药的相关性。结果:甲氧苄啶-磺胺甲恶唑耐药率最高(72%)、阿米卡星(70%)、左氧氟沙星(68%)、庆大霉素(56%)、头孢他啶(56%)、头孢曲松(51%),亚胺培南耐药率最低(10%)。31%的分离株具有多重耐药(MDR)。分子分布检测显示,oqxA和oqxB基因分别占57%和56%。qepA基因的频率为21%。oqxA/oqxB和qepA外排基因的存在与氟喹诺酮和β -内酰胺耐药表型显著相关(P < 0.05)。结论:外排基因的高频率表明该耐药机制是肺炎克雷伯菌分离株的主要耐药途径,并伴有其他耐药机制。有必要采取适当的治疗,以减少耐药的发生。
{"title":"Detection of OqxAB and QepA Efflux Pumps and Their Association with Antibiotic Resistance in Klebsiella pneumoniae Isolated From Urinary Tract Infection","authors":"Manijeh Dehnamaki, M. Ghane, L. Babaeekhou","doi":"10.5812/iji.107397","DOIUrl":"https://doi.org/10.5812/iji.107397","url":null,"abstract":"Background: The emergence and spread of drug resistance among Klebsiella pneumoniae clinical isolates have limited the treatment options for these bacteria. Efflux pumps are considered as one of the key mechanisms of antibiotic resistance in K. pneumoniae isolates. Objectives: The present study aimed to detect oqxA, oqxB, and qepA efflux genes in K. pneumoniae isolated from urinary tract infection (UTI) and survey their association with antibiotic resistance. Methods: In total, 100 K. pneumoniae isolates were obtained from urine samples, and an antimicrobial susceptibility test was conducted using the disk diffusion method according to the Clinical and Laboratory Standards Institute (CLSI) instructions. Polymerase chain reaction (PCR) was done for the detection of efflux pump genes including, oqxA, oqxB, and qepA, and their association was statistically analyzed with resistance to antibiotics. Results: The highest rate of resistance was obtained against trimethoprim-sulfamethoxazole (72%), amikacin (70%), levofloxacin (68%), gentamicin (56%), ceftazidime (56%), and ceftriaxone (51%), and the lowest resistance was against imipenem (10%). Thirty one percent of isolates were multidrug resistant (MDR). Molecular distribution test showed that 57% and 56% of isolates carried the oqxA and oqxB genes, respectively. Also, the frequency of qepA genes was 21%. The presence of oqxA/oqxB and qepA efflux genes were significantly associated with fluoroquinolone and beta-lactam resistance phenotypes (P < 0.05). Conclusions: The high frequency of efflux genes showed that this resistance mechanism is the main way, along with other resistance mechanisms in K. pneumoniae isolates. It is necessary to adopt appropriate treatment to reduce the incidence of resistance.","PeriodicalId":13989,"journal":{"name":"International Journal of Infection","volume":"142 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86952387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Emergency Management Strategies for Children with Rheumatic Disease During COVID-19 Epidemic Outside Hubei in China 湖北以外地区新冠肺炎疫情期间儿童风湿病应急管理策略
Pub Date : 2020-10-26 DOI: 10.5812/iji.106455
Xinyi Wei, Xiao-dong Sun, Zhi Chen, Xiao-Yu Du, Jing Li, Omar Mechali, Chun Jiang, Wei Zhang
Background: Since December 2019, many patients with novel coronavirus pneumonia (NCP) have appeared in Wuhan, Hubei Province, China. The pneumonia was caused by a novel coronavirus named “coronavirus disease 2019, COVID-19” by the WHO on February 11, 2020. The COVID-19 outbreak has created a global public health crisis, and the challenge of combatting this pandemic and its impact is daunting. At present, vaccines and prophylactic therapies for COVID-19 are not available. What we can do now is to aggressively implement infection control measures to prevent the spread of COVID-19 via human-to-human transmission. Objectives: The study aimed to summarize the effect of classification and division management methods on the prevention and control of COVID-19 in the Pediatric Immunology and Rheumatology Department. Methods: Corresponding and targeted medical countermeasures for the prevention and control of COVID-19 from the aspects of personnel, ward, and process management were retrospectively analyzed. Results: From January 16, 2020, to July 31, 2020, there were 11,000 outpatients with rheumatic disease visiting our hospital and 565 children with rheumatic diseases hospitalized in our department. All the patients received timely and reasonable treatment. None of the patients, their caregivers, or medical staff acquired COVID-19 infection in our department, and no suspected COVID-19 case was confirmed in our ward. Conclusions: The model of classification and division management ensured the orderly and safe treatment of children with rheumatic disease during the epidemic prevention and control period, and protected the medical staff from occupational injuries at work, and brought the pandemic under control.
背景:2019年12月以来,中国湖北省武汉市出现多例新型冠状病毒肺炎(NCP)患者。这种肺炎是由世界卫生组织于2020年2月11日命名为“冠状病毒病2019,COVID-19”的新型冠状病毒引起的。2019冠状病毒病疫情造成了一场全球公共卫生危机,抗击这一流行病及其影响的挑战是艰巨的。目前,没有针对COVID-19的疫苗和预防性疗法。我们现在能做的是积极实施感染控制措施,防止COVID-19通过人际传播传播。目的:总结分类分区管理方法在小儿免疫风湿病科防控新冠肺炎中的效果。方法:从人员管理、病房管理、流程管理等方面回顾性分析相应的针对性医疗防控对策。结果:2020年1月16日至2020年7月31日,我院共接待风湿病门诊患者11000人次,住院风湿病患儿565例。所有患者均得到了及时合理的治疗。我科无患者、护理人员、医护人员感染新冠肺炎病例,科室无确诊疑似病例。结论:分级分级管理模式确保了疫情防控期间风湿病患儿的有序、安全治疗,保障了医护人员在工作中免受职业伤害,疫情得到有效控制。
{"title":"Emergency Management Strategies for Children with Rheumatic Disease During COVID-19 Epidemic Outside Hubei in China","authors":"Xinyi Wei, Xiao-dong Sun, Zhi Chen, Xiao-Yu Du, Jing Li, Omar Mechali, Chun Jiang, Wei Zhang","doi":"10.5812/iji.106455","DOIUrl":"https://doi.org/10.5812/iji.106455","url":null,"abstract":"Background: Since December 2019, many patients with novel coronavirus pneumonia (NCP) have appeared in Wuhan, Hubei Province, China. The pneumonia was caused by a novel coronavirus named “coronavirus disease 2019, COVID-19” by the WHO on February 11, 2020. The COVID-19 outbreak has created a global public health crisis, and the challenge of combatting this pandemic and its impact is daunting. At present, vaccines and prophylactic therapies for COVID-19 are not available. What we can do now is to aggressively implement infection control measures to prevent the spread of COVID-19 via human-to-human transmission. Objectives: The study aimed to summarize the effect of classification and division management methods on the prevention and control of COVID-19 in the Pediatric Immunology and Rheumatology Department. Methods: Corresponding and targeted medical countermeasures for the prevention and control of COVID-19 from the aspects of personnel, ward, and process management were retrospectively analyzed. Results: From January 16, 2020, to July 31, 2020, there were 11,000 outpatients with rheumatic disease visiting our hospital and 565 children with rheumatic diseases hospitalized in our department. All the patients received timely and reasonable treatment. None of the patients, their caregivers, or medical staff acquired COVID-19 infection in our department, and no suspected COVID-19 case was confirmed in our ward. Conclusions: The model of classification and division management ensured the orderly and safe treatment of children with rheumatic disease during the epidemic prevention and control period, and protected the medical staff from occupational injuries at work, and brought the pandemic under control.","PeriodicalId":13989,"journal":{"name":"International Journal of Infection","volume":"39 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79404422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infliximab is the Conventional Trick for Ulcerative Colitis as a Novel Therapeutic Option Against SARS-CoV-2 Infection 英夫利西单抗是治疗溃疡性结肠炎的传统疗法,也是抗击 SARS-CoV-2 感染的新疗法选择
Pub Date : 2020-10-20 DOI: 10.5812/IJI.108502
M. Keikha
{"title":"Infliximab is the Conventional Trick for Ulcerative Colitis as a Novel Therapeutic Option Against SARS-CoV-2 Infection","authors":"M. Keikha","doi":"10.5812/IJI.108502","DOIUrl":"https://doi.org/10.5812/IJI.108502","url":null,"abstract":"<jats:p />","PeriodicalId":13989,"journal":{"name":"International Journal of Infection","volume":"31 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77783843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential Drugs for Treating COVID-19 Infection 治疗COVID-19感染的潜在药物
Pub Date : 2020-10-10 DOI: 10.5812/iji.106243
Mehrdad Mohammadi, Tim Sandle, Sajad Rajabi, A. Khorshidi, A. Piroozmand
: The novel Coronavirus Disease 2019 (COVID-19) appeared as an emerging respiratory disease in December 2019 in Wuhan, Hubei province, China, and then spread rapidly worldwide, being declared a pandemic on March 11, 2020. Researchers are attempting to discover specifically designed antiviral treatments for COVID-19. Several therapeutic agents such as Interferon-α, Lopinavir/Ritonavir, Ribavirin, Chloroquine, Chloroquine phosphate, Hydroxychloroquine, Arbidol, Favipiravir, Remdesivir, Darunavir, Imatinib, Teicoplanin, Azithromycin, COVID-19 convalescent plasma, other potential antiviral drugs, and Chinese herbal agents are now being clinically studied to examine both pharmaceutical efficacy and safety for COVID-19 treatment in several countries. Some favorable results from these studies have been obtained to date. This review article summarizes and reiterates drugs that are potentially efficient against COVID-19.
新型冠状病毒病2019 (COVID-19)于2019年12月在中国湖北省武汉市作为一种新兴呼吸道疾病出现,随后在全球迅速传播,于2020年3月11日被宣布为大流行。研究人员正试图发现针对COVID-19的专门设计的抗病毒治疗方法。目前,一些国家正在临床研究干扰素-α、洛匹那韦/利托那韦、利巴韦林、氯喹、磷酸氯喹、羟氯喹、阿比多尔、法匹拉韦、瑞德西韦、达若那韦、伊马替尼、替可普兰宁、阿奇霉素、COVID-19恢复期血浆、其他潜在抗病毒药物和中草药等治疗药物,以检查治疗COVID-19的药物疗效和安全性。迄今为止,这些研究取得了一些有利的结果。这篇综述文章总结并重申了可能有效对抗COVID-19的药物。
{"title":"Potential Drugs for Treating COVID-19 Infection","authors":"Mehrdad Mohammadi, Tim Sandle, Sajad Rajabi, A. Khorshidi, A. Piroozmand","doi":"10.5812/iji.106243","DOIUrl":"https://doi.org/10.5812/iji.106243","url":null,"abstract":": The novel Coronavirus Disease 2019 (COVID-19) appeared as an emerging respiratory disease in December 2019 in Wuhan, Hubei province, China, and then spread rapidly worldwide, being declared a pandemic on March 11, 2020. Researchers are attempting to discover specifically designed antiviral treatments for COVID-19. Several therapeutic agents such as Interferon-α, Lopinavir/Ritonavir, Ribavirin, Chloroquine, Chloroquine phosphate, Hydroxychloroquine, Arbidol, Favipiravir, Remdesivir, Darunavir, Imatinib, Teicoplanin, Azithromycin, COVID-19 convalescent plasma, other potential antiviral drugs, and Chinese herbal agents are now being clinically studied to examine both pharmaceutical efficacy and safety for COVID-19 treatment in several countries. Some favorable results from these studies have been obtained to date. This review article summarizes and reiterates drugs that are potentially efficient against COVID-19.","PeriodicalId":13989,"journal":{"name":"International Journal of Infection","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79357753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Role of Self-Responsible Response Versus Lockdown Approach in Controlling COVID-19 Pandemic in Kurdistan Region of Iraq 在伊拉克库尔德斯坦地区控制 COVID-19 大流行中,自我响应与封锁方法的作用
Pub Date : 2020-09-01 DOI: 10.5812/iji.107092
N. Hussein
{"title":"The Role of Self-Responsible Response Versus Lockdown Approach in Controlling COVID-19 Pandemic in Kurdistan Region of Iraq","authors":"N. Hussein","doi":"10.5812/iji.107092","DOIUrl":"https://doi.org/10.5812/iji.107092","url":null,"abstract":"<jats:p />","PeriodicalId":13989,"journal":{"name":"International Journal of Infection","volume":"93 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84341220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
N-acetylcysteine in Severe COVID-19: The Possible Mechanism N-乙酰半胱氨酸治疗严重 COVID-19:可能的机制
Pub Date : 2020-08-31 DOI: 10.5812/iji.106361
Md. Jahidul Hasan
{"title":"N-acetylcysteine in Severe COVID-19: The Possible Mechanism","authors":"Md. Jahidul Hasan","doi":"10.5812/iji.106361","DOIUrl":"https://doi.org/10.5812/iji.106361","url":null,"abstract":"<jats:p />","PeriodicalId":13989,"journal":{"name":"International Journal of Infection","volume":"40 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78343363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Space-Time Cluster Analysis of Malaria in Fars Province-Iran 伊朗法尔斯省疟疾时空聚类分析
Pub Date : 2020-08-24 DOI: 10.5812/IJI.107238
A. Rezaianzadeh, M. Zare, M. Aliakbarpoor, H. Faramarzi, M. Ebrahimi
Background: Malaria, a mosquito-borne infection, is caused by protozoan parasites invading the red blood cells of both humans and animals. Iran is an endemic site for malaria with 1 - 10 cases per one million dwellers, in which 90% of cases occur in southern parts of Iran. Objectives: to detect space-time clusters of Malaria in Fars province-Iran during 1/1/2011 and 31/12/2015. Methods: 357 malaria cases were recorded from 19 cities of Fars province. Permutation scan modeling was applied retrospectively to detect the outbreaks of malaria during 1/1/2011 and 31/12/2015. SPSS V. 22, ITSM V. 2002, ArcGIS10, and SaTScan9.4.4 software tools were used. The significance level was considered 0.05. Results: Based on the results of the current study, 5 space-time clusters were discovered for malaria, indicating that malaria followed a time-space trend in the area (P value < 0.05). The Most Likely Cluster (MLC) contained almost 50% (6/12) of all cases during 1/7/2015 and 31/7/2015 in Firoozabad (P < 0.05); however, non-statistically significant clusters were detected which had clinically important information on the canons of the outbreaks. Conclusions: Malaria did not occur uniformly in Fars province during 1/1/2011 and 31/12/2015. Detected space-time clusters could help Public health managers and policymakers dedicating clinical staff and facilities to more needy areas and consequently reduce the rate of disease in the area.
背景:疟疾是一种蚊媒感染,由原虫寄生虫侵入人类和动物的红细胞引起。伊朗是疟疾流行地,每100万居民中有1 - 10例疟疾病例,其中90%的病例发生在伊朗南部地区。目的:检测2011年1月1日至2015年12月31日伊朗法尔斯省疟疾时空聚类。方法:对法尔斯省19个城市357例疟疾病例进行调查。应用排列扫描模型对2011年1月1日至2015年12月31日期间的疟疾疫情进行回顾性检测。采用SPSS V. 22、ITSM V. 2002、ArcGIS10、SaTScan9.4.4软件工具。认为显著性水平为0.05。结果:在本研究的基础上,发现了疟疾的5个时空聚类,表明该地区疟疾具有一定的时空趋势(P值< 0.05)。2015年1月7日至2015年7月31日期间,Firoozabad最可能聚集群(MLC)占所有病例的近50% (6/12)(P < 0.05);然而,检测到的非统计显着的聚集性具有有关暴发的临床重要信息。结论:2011年1月1日和2015年12月31日,法尔斯省的疟疾发病情况并不均匀。探测到的时空集群可以帮助公共卫生管理人员和政策制定者将临床工作人员和设施投入到更需要的地区,从而降低该地区的发病率。
{"title":"Space-Time Cluster Analysis of Malaria in Fars Province-Iran","authors":"A. Rezaianzadeh, M. Zare, M. Aliakbarpoor, H. Faramarzi, M. Ebrahimi","doi":"10.5812/IJI.107238","DOIUrl":"https://doi.org/10.5812/IJI.107238","url":null,"abstract":"Background: Malaria, a mosquito-borne infection, is caused by protozoan parasites invading the red blood cells of both humans and animals. Iran is an endemic site for malaria with 1 - 10 cases per one million dwellers, in which 90% of cases occur in southern parts of Iran. Objectives: to detect space-time clusters of Malaria in Fars province-Iran during 1/1/2011 and 31/12/2015. Methods: 357 malaria cases were recorded from 19 cities of Fars province. Permutation scan modeling was applied retrospectively to detect the outbreaks of malaria during 1/1/2011 and 31/12/2015. SPSS V. 22, ITSM V. 2002, ArcGIS10, and SaTScan9.4.4 software tools were used. The significance level was considered 0.05. Results: Based on the results of the current study, 5 space-time clusters were discovered for malaria, indicating that malaria followed a time-space trend in the area (P value < 0.05). The Most Likely Cluster (MLC) contained almost 50% (6/12) of all cases during 1/7/2015 and 31/7/2015 in Firoozabad (P < 0.05); however, non-statistically significant clusters were detected which had clinically important information on the canons of the outbreaks. Conclusions: Malaria did not occur uniformly in Fars province during 1/1/2011 and 31/12/2015. Detected space-time clusters could help Public health managers and policymakers dedicating clinical staff and facilities to more needy areas and consequently reduce the rate of disease in the area.","PeriodicalId":13989,"journal":{"name":"International Journal of Infection","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87312332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
期刊
International Journal of Infection
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1